Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcare

Prognostic Implications of Multiplex Detection ofKRASMutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma

(2018) Min Kyeong Kim et al.   CLINICAL CHEMISTRY

The crucial role of multiomic approach in cancer research and clinically relevant outcomes

(2018) Miaolong Lu et al.   EPMA Journal

Reduced levels of N’-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival

(2017) Kyung-Hee Kim et al.   Oncotarget

Pattern recognition for predictive, preventive, and personalized medicine in cancer

(2017) Tingting Cheng et al.   EPMA Journal

CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma

(2017) Sven H. Loosen et al.   Scientific Reports

Fighting Global Disparities in Cancer Care: A Surgical Oncology View

(2016) Harald J. Hoekstra et al.   ANNALS OF SURGICAL ONCOLOGY

Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study

(2016) Tilman Kühn et al.   BMC Medicine

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Pancreatic cancer

(2016) Terumi Kamisawa et al.   LANCET

Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies

(2016) S. Volik et al.   MOLECULAR CANCER RESEARCH

Low-mass-ion discriminant equation (LOME) for ovarian cancer screening

(2016) Jun Hwa Lee et al.   BioData Mining

The molecular mechanism by which saturated lysophosphatidylcholine attenuates the metastatic capacity of melanoma cells

(2016) Thomas Ross et al.   FEBS Open Bio

Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3rdEnglish edition

(2015) Masaru Miyazaki et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling

(2015) Haiyu Zhang et al.   Molecular BioSystems

Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer

(2015) Efrosini Barbayianni et al.   PROGRESS IN LIPID RESEARCH

Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer

(2015) Takayuki Goto et al.   PROSTATE

Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study

(2015) Ming-zhu Yin et al.   TUMOR BIOLOGY

PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA

(2015) Seung Tae Kim et al.   Oncotarget

EPMA position paper in cancer: current overview and future perspectives

(2015) Godfrey Grech et al.   EPMA Journal

MicroRNA Markers for the Diagnosis of Pancreatic and Biliary-Tract Cancers

(2015) Motohiro Kojima et al.   PLoS One

The Early Detection of Pancreatic Cancer: What Will It Take to Diagnose and Treat Curable Pancreatic Neoplasia?

(2014) A. M. Lennon et al.   CANCER RESEARCH

The promise of methylation on beads for cancer detection and treatment

(2014) Angela A Guzzetta et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method

(2014) XIAOFENG XU et al.   Molecular Medicine Reports

Differential levels of L-homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer

(2014) SEUNG CHEOL KIM et al.   Oncology Letters

Development and Validation of a Highly Sensitive Urine-Based Test to Identify Patients with Colonic Adenomatous Polyps

(2014) Haili Wang et al.   Clinical and Translational Gastroenterology

Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer

(2013) J. M. Yi et al.   CLINICAL CANCER RESEARCH

Low-mass-ion discriminant equation: A new concept for colorectal cancer screening

(2013) Jun Hwa Lee et al.   INTERNATIONAL JOURNAL OF CANCER

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

(2013) Yizhou Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma

(2013) Manuel Rodríguez-Perálvarez et al.   JOURNAL OF HEPATOLOGY

Global and Targeted Metabolomics of Esophageal Squamous Cell Carcinoma Discovers Potential Diagnostic and Therapeutic Biomarkers

(2013) Jing Xu et al.   MOLECULAR & CELLULAR PROTEOMICS

Early diagnosis of pancreatic cancer: challenges and new developments

(2012) Sukhwinder Kaur et al.   Biomarkers in Medicine

Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry

(2012) Tao Zhang et al.   CLINICA CHIMICA ACTA

Endoscopic Ultrasound for Differential Diagnosis of Duodenal Lesions

(2012) A. Pavlovic Markovic et al.   ULTRASCHALL IN DER MEDIZIN

Nomogram for Predicting the Benefit of Adjuvant Chemoradiotherapy for Resected Gallbladder Cancer

(2011) Samuel J. Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin-Mediated B16.F10 Melanoma Cell Adhesion In vitro and Inhibits Metastasis-Like Lung Invasion In vivo

(2011) P. Jantscheff et al.   MOLECULAR CANCER THERAPEUTICS

In vivo1H MRS in the assessment of the therapeutic response of breast cancer patients

(2011) Uma Sharma et al.   NMR IN BIOMEDICINE

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE